I would like to personally welcome everyone to San Diego and invite all 2017 Vascular Annual Meeting attendees to visit the Spring Meeting of the Vascular and Endovascular Surgery Society (VESS).
This year’s program will be held on Wednesday, May 31, and comprises two informative paper sessions from 7:30 to 11:30 a.m. and 12:30 to 4:00 p.m.in the San Diego Convention Center Room 6F (upper level).
Courtesy VESS
Dr. Peter NelsonDr. Bernadette Aulivola and the VESS Program Committee, in collaboration with the SVS Program Committee, have selected 30 timely research papers for presentation. The format of the meeting allows for open discussion between the presenters, discussants (all of whom will be VESS Candidate Members), and attendees. I am sure you will enjoy the experience and we welcome your participation.
Founded in 1976 by 19 forward-thinking young vascular surgeons, VESS has grown to become a prominent national and international organization boasting over 1,000 members.
Focused on young vascular surgeons in both academic and community practice, VESS offers excellent educational opportunities, competitive research grant programs, and networking opportunities for career growth. A few examples include the resident/fellow research award, the junior faculty research award, the VESS travel grant, the Women and Diversity Meet the Leaders Mentor Program, and the resident/fellows career development symposium and emerging technology forum.
In line with these priorities, VESS is co-sponsoring along with SVS Young Surgeons’ Committee the VAM General Surgery Resident/Medical Student Program Welcome Reception on Wednesday, May 31, from 6:45 to 7:45 p.m. in Marina Ballroom D at the Marriott Marquis. Please come by and interact with future vascular surgeons from across the country.
The VESS Annual Meeting is held in the winter each year and is a highlight of the academic year for all members, families, and sponsors alike. The annual meeting is a special time to share research, contribute ideas, learn new technologies, and make lifelong friends. The next annual meeting will take place January 31 – February 4, 2018 (just prior to the next New England Patriots SuperBowl victory), and will be convened at the newly renovated Vail Cascade Resort and Spa, Vail, Colo.
The weekend will feature high-caliber research presentations, open interactive discussion, and hands-on simulation programs, blended with exciting social events all set in 5,200 acres of pristine ski and snowboard terrain with activities for the entire family. I encourage you to take advantage of everything the unique setting of the Annual Meeting has to offer.
I would like to personally welcome everyone to San Diego and invite all 2017 Vascular Annual Meeting attendees to visit the Spring Meeting of the Vascular and Endovascular Surgery Society (VESS).
This year’s program will be held on Wednesday, May 31, and comprises two informative paper sessions from 7:30 to 11:30 a.m. and 12:30 to 4:00 p.m.in the San Diego Convention Center Room 6F (upper level).
Courtesy VESS
Dr. Peter NelsonDr. Bernadette Aulivola and the VESS Program Committee, in collaboration with the SVS Program Committee, have selected 30 timely research papers for presentation. The format of the meeting allows for open discussion between the presenters, discussants (all of whom will be VESS Candidate Members), and attendees. I am sure you will enjoy the experience and we welcome your participation.
Founded in 1976 by 19 forward-thinking young vascular surgeons, VESS has grown to become a prominent national and international organization boasting over 1,000 members.
Focused on young vascular surgeons in both academic and community practice, VESS offers excellent educational opportunities, competitive research grant programs, and networking opportunities for career growth. A few examples include the resident/fellow research award, the junior faculty research award, the VESS travel grant, the Women and Diversity Meet the Leaders Mentor Program, and the resident/fellows career development symposium and emerging technology forum.
In line with these priorities, VESS is co-sponsoring along with SVS Young Surgeons’ Committee the VAM General Surgery Resident/Medical Student Program Welcome Reception on Wednesday, May 31, from 6:45 to 7:45 p.m. in Marina Ballroom D at the Marriott Marquis. Please come by and interact with future vascular surgeons from across the country.
The VESS Annual Meeting is held in the winter each year and is a highlight of the academic year for all members, families, and sponsors alike. The annual meeting is a special time to share research, contribute ideas, learn new technologies, and make lifelong friends. The next annual meeting will take place January 31 – February 4, 2018 (just prior to the next New England Patriots SuperBowl victory), and will be convened at the newly renovated Vail Cascade Resort and Spa, Vail, Colo.
The weekend will feature high-caliber research presentations, open interactive discussion, and hands-on simulation programs, blended with exciting social events all set in 5,200 acres of pristine ski and snowboard terrain with activities for the entire family. I encourage you to take advantage of everything the unique setting of the Annual Meeting has to offer.
I would like to personally welcome everyone to San Diego and invite all 2017 Vascular Annual Meeting attendees to visit the Spring Meeting of the Vascular and Endovascular Surgery Society (VESS).
This year’s program will be held on Wednesday, May 31, and comprises two informative paper sessions from 7:30 to 11:30 a.m. and 12:30 to 4:00 p.m.in the San Diego Convention Center Room 6F (upper level).
Courtesy VESS
Dr. Peter NelsonDr. Bernadette Aulivola and the VESS Program Committee, in collaboration with the SVS Program Committee, have selected 30 timely research papers for presentation. The format of the meeting allows for open discussion between the presenters, discussants (all of whom will be VESS Candidate Members), and attendees. I am sure you will enjoy the experience and we welcome your participation.
Founded in 1976 by 19 forward-thinking young vascular surgeons, VESS has grown to become a prominent national and international organization boasting over 1,000 members.
Focused on young vascular surgeons in both academic and community practice, VESS offers excellent educational opportunities, competitive research grant programs, and networking opportunities for career growth. A few examples include the resident/fellow research award, the junior faculty research award, the VESS travel grant, the Women and Diversity Meet the Leaders Mentor Program, and the resident/fellows career development symposium and emerging technology forum.
In line with these priorities, VESS is co-sponsoring along with SVS Young Surgeons’ Committee the VAM General Surgery Resident/Medical Student Program Welcome Reception on Wednesday, May 31, from 6:45 to 7:45 p.m. in Marina Ballroom D at the Marriott Marquis. Please come by and interact with future vascular surgeons from across the country.
The VESS Annual Meeting is held in the winter each year and is a highlight of the academic year for all members, families, and sponsors alike. The annual meeting is a special time to share research, contribute ideas, learn new technologies, and make lifelong friends. The next annual meeting will take place January 31 – February 4, 2018 (just prior to the next New England Patriots SuperBowl victory), and will be convened at the newly renovated Vail Cascade Resort and Spa, Vail, Colo.
The weekend will feature high-caliber research presentations, open interactive discussion, and hands-on simulation programs, blended with exciting social events all set in 5,200 acres of pristine ski and snowboard terrain with activities for the entire family. I encourage you to take advantage of everything the unique setting of the Annual Meeting has to offer.
The 2016 Vascular Quality Initiative’s inaugural annual meeting proved so popular that the one-day session has been expanded by a half-day, and a networking reception and poster abstract session added.
VQI@VAM kicks off at noon Tuesday, May 30, and continues all day Wednesday, May 31. Day Two coincides with opening day of the Vascular Annual Meeting.
“Participants were very positive about all the content we offered last year,” said Dr. Jens Eldrup-Jorgensen, VQI’s new medical director. It was also a very full day. With attendees interested in learning more, expanding the meeting became essential.
Dr. Jens Eldrup Jorgensen
“Data managers wanted two additions: more detailed information about the registries and content specific to data managers that would cover all the registries, plus more time to network, to have time to share information and best practices with people from other institutions.”
The additional half day is specifically dedicated to data managers. Concurrent sessions will permit the managers to attend sessions on the registries most interesting to them, diving deeply into the data. Popular topics, such as the registries for Endovascular AAA Repair and Peripheral Vascular Intervention, will be repeated so attendees have more than one opportunity to review that information.
Adding the posters and networking reception at the end of the first day adds another dimension to the meeting. The posters will cover quality improvement or improvement in the processes of using the registries, such as how best to enter data to create reports or how to use that data for quality improvement projects. With posters presented during the reception, all participants can converse with others on best practices and how to solve problems, said Dr. Eldrup-Jorensen.
The reception and poster session will be from 5 to 6:30 p.m.
VQI@ VAM continues from 8 a.m. to 5 p.m. Wednesday, May 31. At 12 p.m., Dr. Eldrup-Jorgensen, VQI’s will present the Keynote Address, “National Quality Initiatives and Critical Priorities for the VQI.”
The 2016 Vascular Quality Initiative’s inaugural annual meeting proved so popular that the one-day session has been expanded by a half-day, and a networking reception and poster abstract session added.
VQI@VAM kicks off at noon Tuesday, May 30, and continues all day Wednesday, May 31. Day Two coincides with opening day of the Vascular Annual Meeting.
“Participants were very positive about all the content we offered last year,” said Dr. Jens Eldrup-Jorgensen, VQI’s new medical director. It was also a very full day. With attendees interested in learning more, expanding the meeting became essential.
Dr. Jens Eldrup Jorgensen
“Data managers wanted two additions: more detailed information about the registries and content specific to data managers that would cover all the registries, plus more time to network, to have time to share information and best practices with people from other institutions.”
The additional half day is specifically dedicated to data managers. Concurrent sessions will permit the managers to attend sessions on the registries most interesting to them, diving deeply into the data. Popular topics, such as the registries for Endovascular AAA Repair and Peripheral Vascular Intervention, will be repeated so attendees have more than one opportunity to review that information.
Adding the posters and networking reception at the end of the first day adds another dimension to the meeting. The posters will cover quality improvement or improvement in the processes of using the registries, such as how best to enter data to create reports or how to use that data for quality improvement projects. With posters presented during the reception, all participants can converse with others on best practices and how to solve problems, said Dr. Eldrup-Jorensen.
The reception and poster session will be from 5 to 6:30 p.m.
VQI@ VAM continues from 8 a.m. to 5 p.m. Wednesday, May 31. At 12 p.m., Dr. Eldrup-Jorgensen, VQI’s will present the Keynote Address, “National Quality Initiatives and Critical Priorities for the VQI.”
The 2016 Vascular Quality Initiative’s inaugural annual meeting proved so popular that the one-day session has been expanded by a half-day, and a networking reception and poster abstract session added.
VQI@VAM kicks off at noon Tuesday, May 30, and continues all day Wednesday, May 31. Day Two coincides with opening day of the Vascular Annual Meeting.
“Participants were very positive about all the content we offered last year,” said Dr. Jens Eldrup-Jorgensen, VQI’s new medical director. It was also a very full day. With attendees interested in learning more, expanding the meeting became essential.
Dr. Jens Eldrup Jorgensen
“Data managers wanted two additions: more detailed information about the registries and content specific to data managers that would cover all the registries, plus more time to network, to have time to share information and best practices with people from other institutions.”
The additional half day is specifically dedicated to data managers. Concurrent sessions will permit the managers to attend sessions on the registries most interesting to them, diving deeply into the data. Popular topics, such as the registries for Endovascular AAA Repair and Peripheral Vascular Intervention, will be repeated so attendees have more than one opportunity to review that information.
Adding the posters and networking reception at the end of the first day adds another dimension to the meeting. The posters will cover quality improvement or improvement in the processes of using the registries, such as how best to enter data to create reports or how to use that data for quality improvement projects. With posters presented during the reception, all participants can converse with others on best practices and how to solve problems, said Dr. Eldrup-Jorensen.
The reception and poster session will be from 5 to 6:30 p.m.
VQI@ VAM continues from 8 a.m. to 5 p.m. Wednesday, May 31. At 12 p.m., Dr. Eldrup-Jorgensen, VQI’s will present the Keynote Address, “National Quality Initiatives and Critical Priorities for the VQI.”
To help SVS members learn the necessary steps of setting up a multicenter clinical research study, this year’s Vascular Annual Meeting offers “The Nuts and Bolts of a Multicenter Clinical Trial.” The concurrent session will be held from 5 to 6:30 p.m. Wednesday, VAM’s opening day.
“The most accepted method of definitively answering questions is a clinical trial,” said SVS Clinical Research Committee Chair and co-moderator, Dr. Raul Guzman. Though many SVS members have participated in multicenter trials, “They’re not easy endeavors,” said Dr. Guzman. “It takes time, commitment and money to really push forward an idea for a multicenter trial from the ground up.”
Dr. Raul GuzmanSession organizers from the Clinical Research Committee believe many investigators within the vascular community are interested in taking one of their questions and answering it decisively.
“Nuts and Bolts” will provide an insider’s view of effective approaches and processes for launching a multicenter clinical trial, focusing on the best strategies and the challenges involved. “We hope that at the end of the session, attendees will have sufficient detail about this process so they could begin their own trial. We want to provide an initial education,” Dr. Guzman said.
Speakers include SVS members who are successful clinical investigators:
Dr. Brajesh Lal, will speak on “How to Get Started – Perspectives from CREST and CREST-2”
Dr. Alik Farber, “Trial Execution – Tips from the BEST-CLI Trial Investigators”
Dr. B. Timothy Baxter, “The End Game, Finishing Your Trial – How We Did It in NTA^3CT”
Dr. C. Keith Ozaki, “The Small Multicenter Randomized Trial – Involving Your Friends and Neighbors”
Dr. Philip Goodney, “Patient-Oriented Research – A Multicenter Approach to PCORI Trials”
“A discussion about how to overcome challenges and avoid potential pitfalls that can be encountered during the various stages of trial execution are an important part of the course. “Our speakers will discuss not only what they did well, but what they could do better,” said Dr. Guzman.
Many members have questions that need answers, he said. “I would venture to say that most SVS members have had an idea for a clinical trial. They’ve formed the basis of a trial but there are so many challenges that they’ve been discouraged. One of the questions is, “Where do you even start?’
“We think we’ll be able to answer that for them,” Dr. Guzman said.
Wednesday, May 31
5 – 6:30 p.m.
C2: The Nuts and Bolts of a Multicenter Clinical Trial
To help SVS members learn the necessary steps of setting up a multicenter clinical research study, this year’s Vascular Annual Meeting offers “The Nuts and Bolts of a Multicenter Clinical Trial.” The concurrent session will be held from 5 to 6:30 p.m. Wednesday, VAM’s opening day.
“The most accepted method of definitively answering questions is a clinical trial,” said SVS Clinical Research Committee Chair and co-moderator, Dr. Raul Guzman. Though many SVS members have participated in multicenter trials, “They’re not easy endeavors,” said Dr. Guzman. “It takes time, commitment and money to really push forward an idea for a multicenter trial from the ground up.”
Dr. Raul GuzmanSession organizers from the Clinical Research Committee believe many investigators within the vascular community are interested in taking one of their questions and answering it decisively.
“Nuts and Bolts” will provide an insider’s view of effective approaches and processes for launching a multicenter clinical trial, focusing on the best strategies and the challenges involved. “We hope that at the end of the session, attendees will have sufficient detail about this process so they could begin their own trial. We want to provide an initial education,” Dr. Guzman said.
Speakers include SVS members who are successful clinical investigators:
Dr. Brajesh Lal, will speak on “How to Get Started – Perspectives from CREST and CREST-2”
Dr. Alik Farber, “Trial Execution – Tips from the BEST-CLI Trial Investigators”
Dr. B. Timothy Baxter, “The End Game, Finishing Your Trial – How We Did It in NTA^3CT”
Dr. C. Keith Ozaki, “The Small Multicenter Randomized Trial – Involving Your Friends and Neighbors”
Dr. Philip Goodney, “Patient-Oriented Research – A Multicenter Approach to PCORI Trials”
“A discussion about how to overcome challenges and avoid potential pitfalls that can be encountered during the various stages of trial execution are an important part of the course. “Our speakers will discuss not only what they did well, but what they could do better,” said Dr. Guzman.
Many members have questions that need answers, he said. “I would venture to say that most SVS members have had an idea for a clinical trial. They’ve formed the basis of a trial but there are so many challenges that they’ve been discouraged. One of the questions is, “Where do you even start?’
“We think we’ll be able to answer that for them,” Dr. Guzman said.
Wednesday, May 31
5 – 6:30 p.m.
C2: The Nuts and Bolts of a Multicenter Clinical Trial
To help SVS members learn the necessary steps of setting up a multicenter clinical research study, this year’s Vascular Annual Meeting offers “The Nuts and Bolts of a Multicenter Clinical Trial.” The concurrent session will be held from 5 to 6:30 p.m. Wednesday, VAM’s opening day.
“The most accepted method of definitively answering questions is a clinical trial,” said SVS Clinical Research Committee Chair and co-moderator, Dr. Raul Guzman. Though many SVS members have participated in multicenter trials, “They’re not easy endeavors,” said Dr. Guzman. “It takes time, commitment and money to really push forward an idea for a multicenter trial from the ground up.”
Dr. Raul GuzmanSession organizers from the Clinical Research Committee believe many investigators within the vascular community are interested in taking one of their questions and answering it decisively.
“Nuts and Bolts” will provide an insider’s view of effective approaches and processes for launching a multicenter clinical trial, focusing on the best strategies and the challenges involved. “We hope that at the end of the session, attendees will have sufficient detail about this process so they could begin their own trial. We want to provide an initial education,” Dr. Guzman said.
Speakers include SVS members who are successful clinical investigators:
Dr. Brajesh Lal, will speak on “How to Get Started – Perspectives from CREST and CREST-2”
Dr. Alik Farber, “Trial Execution – Tips from the BEST-CLI Trial Investigators”
Dr. B. Timothy Baxter, “The End Game, Finishing Your Trial – How We Did It in NTA^3CT”
Dr. C. Keith Ozaki, “The Small Multicenter Randomized Trial – Involving Your Friends and Neighbors”
Dr. Philip Goodney, “Patient-Oriented Research – A Multicenter Approach to PCORI Trials”
“A discussion about how to overcome challenges and avoid potential pitfalls that can be encountered during the various stages of trial execution are an important part of the course. “Our speakers will discuss not only what they did well, but what they could do better,” said Dr. Guzman.
Many members have questions that need answers, he said. “I would venture to say that most SVS members have had an idea for a clinical trial. They’ve formed the basis of a trial but there are so many challenges that they’ve been discouraged. One of the questions is, “Where do you even start?’
“We think we’ll be able to answer that for them,” Dr. Guzman said.
Wednesday, May 31
5 – 6:30 p.m.
C2: The Nuts and Bolts of a Multicenter Clinical Trial
I always enjoy our Vascular Annual Meeting, and I look forward to it for months. It’s the leading forum for important and cutting-edge clinical and translational research, with presenters and attendees from across the country and around the world.
Come join us in San Diego May 31 to June 3 for the pre-eminent educational and social networking event of the year in vascular surgery and endovascular therapy. With all the changes coming in medicine and the health care system, this is the perfect chance to gather with health care professionals who are focused on the comprehensive and longitudinal care of patients with vascular disease.
Dr. Ron FairmanHere are some highlights:
Collaboration: Multiple joint sessions, reflecting multidisciplinary and collaborative approaches providing our patients the best possible vascular care. We have sessions with a virtual alphabet soup of allied societies: APMA, AVF, ESVS, STS, SVM, SVN and SVU.
Expanded programming: Sessions have been added on both Wednesday and Saturday, so plan your travel accordingly. Member registrants enjoy free admission to Wednesday’s six postgraduate courses, a $300 value. In addition, VAM includes more concurrent sessions than ever before, plus focused breakfast sessions and video presentations. A revamped workshop schedule also debuts Wednesday.
Updated, new guidelines: We plan a session offering an update on clinical practice guidelines, including hospital privileges, surgical follow-up and care of patients with AAA, plus the unveiling of new global CLI guidelines.
Education credits: CME credits and Maintenance of Certification self-assessment credits are available. Our mobile app makes it easier than ever to take the self-assessment exams via a link within the app.
Community-practice programming: A majority of vascular care is delivered by vascular surgeons working in a community practice setting. To help meet the needs of our community practice members, several sessions this year carry a “seal of approval” from the SVS Community Practice Committee.
Young Surgeon programming: To help our young surgeons navigate VAM more easily, the SVS Young Surgeons Advisory Committee has recommended several sessions and abstracts as being of particular interest to this audience. All are marked with a unique icon to identify the sessions quickly and easily.
Events for our international attendees: Wednesday offers a full day of international programming, kicked off by a new event, “International Consortium of Vascular Registries: Quality Improvement in Vascular Surgery Goes Global.”
Fun: Social events, alumni receptions and other opportunities let attendees catch up with old friends and make new connections. And, we’ll be in beautiful San Diego, so bring the family for a vacation either before or after VAM.
If you haven’t already, register today at vsweb.org/VAM17. I look forward to welcoming all of you and sharing what’s new in our specialty.
I always enjoy our Vascular Annual Meeting, and I look forward to it for months. It’s the leading forum for important and cutting-edge clinical and translational research, with presenters and attendees from across the country and around the world.
Come join us in San Diego May 31 to June 3 for the pre-eminent educational and social networking event of the year in vascular surgery and endovascular therapy. With all the changes coming in medicine and the health care system, this is the perfect chance to gather with health care professionals who are focused on the comprehensive and longitudinal care of patients with vascular disease.
Dr. Ron FairmanHere are some highlights:
Collaboration: Multiple joint sessions, reflecting multidisciplinary and collaborative approaches providing our patients the best possible vascular care. We have sessions with a virtual alphabet soup of allied societies: APMA, AVF, ESVS, STS, SVM, SVN and SVU.
Expanded programming: Sessions have been added on both Wednesday and Saturday, so plan your travel accordingly. Member registrants enjoy free admission to Wednesday’s six postgraduate courses, a $300 value. In addition, VAM includes more concurrent sessions than ever before, plus focused breakfast sessions and video presentations. A revamped workshop schedule also debuts Wednesday.
Updated, new guidelines: We plan a session offering an update on clinical practice guidelines, including hospital privileges, surgical follow-up and care of patients with AAA, plus the unveiling of new global CLI guidelines.
Education credits: CME credits and Maintenance of Certification self-assessment credits are available. Our mobile app makes it easier than ever to take the self-assessment exams via a link within the app.
Community-practice programming: A majority of vascular care is delivered by vascular surgeons working in a community practice setting. To help meet the needs of our community practice members, several sessions this year carry a “seal of approval” from the SVS Community Practice Committee.
Young Surgeon programming: To help our young surgeons navigate VAM more easily, the SVS Young Surgeons Advisory Committee has recommended several sessions and abstracts as being of particular interest to this audience. All are marked with a unique icon to identify the sessions quickly and easily.
Events for our international attendees: Wednesday offers a full day of international programming, kicked off by a new event, “International Consortium of Vascular Registries: Quality Improvement in Vascular Surgery Goes Global.”
Fun: Social events, alumni receptions and other opportunities let attendees catch up with old friends and make new connections. And, we’ll be in beautiful San Diego, so bring the family for a vacation either before or after VAM.
If you haven’t already, register today at vsweb.org/VAM17. I look forward to welcoming all of you and sharing what’s new in our specialty.
Sincerely,
Ronald M. Fairman, MD
SVS President
I always enjoy our Vascular Annual Meeting, and I look forward to it for months. It’s the leading forum for important and cutting-edge clinical and translational research, with presenters and attendees from across the country and around the world.
Come join us in San Diego May 31 to June 3 for the pre-eminent educational and social networking event of the year in vascular surgery and endovascular therapy. With all the changes coming in medicine and the health care system, this is the perfect chance to gather with health care professionals who are focused on the comprehensive and longitudinal care of patients with vascular disease.
Dr. Ron FairmanHere are some highlights:
Collaboration: Multiple joint sessions, reflecting multidisciplinary and collaborative approaches providing our patients the best possible vascular care. We have sessions with a virtual alphabet soup of allied societies: APMA, AVF, ESVS, STS, SVM, SVN and SVU.
Expanded programming: Sessions have been added on both Wednesday and Saturday, so plan your travel accordingly. Member registrants enjoy free admission to Wednesday’s six postgraduate courses, a $300 value. In addition, VAM includes more concurrent sessions than ever before, plus focused breakfast sessions and video presentations. A revamped workshop schedule also debuts Wednesday.
Updated, new guidelines: We plan a session offering an update on clinical practice guidelines, including hospital privileges, surgical follow-up and care of patients with AAA, plus the unveiling of new global CLI guidelines.
Education credits: CME credits and Maintenance of Certification self-assessment credits are available. Our mobile app makes it easier than ever to take the self-assessment exams via a link within the app.
Community-practice programming: A majority of vascular care is delivered by vascular surgeons working in a community practice setting. To help meet the needs of our community practice members, several sessions this year carry a “seal of approval” from the SVS Community Practice Committee.
Young Surgeon programming: To help our young surgeons navigate VAM more easily, the SVS Young Surgeons Advisory Committee has recommended several sessions and abstracts as being of particular interest to this audience. All are marked with a unique icon to identify the sessions quickly and easily.
Events for our international attendees: Wednesday offers a full day of international programming, kicked off by a new event, “International Consortium of Vascular Registries: Quality Improvement in Vascular Surgery Goes Global.”
Fun: Social events, alumni receptions and other opportunities let attendees catch up with old friends and make new connections. And, we’ll be in beautiful San Diego, so bring the family for a vacation either before or after VAM.
If you haven’t already, register today at vsweb.org/VAM17. I look forward to welcoming all of you and sharing what’s new in our specialty.
Aerosolized MMR vaccine can be used in booster campaigns in school-age children for measles and rubella, said José Luis Díaz Ortega, MD, of the Instituto Nacional de Salud Pública, Mexico, and his associates.
However, more studies of school-age children with longer follow-up of mumps antibody persistence are needed, they said.
CDC/ Cynthia S. Goldsmith; William Bellini, Ph.D.
Measles vironA 1-year serological follow-up study was done in 241 Mexican children aged 6-7 years who received vaccine MMR SII (Serum Institute of India) administered by aerosol or injection or MMR II (Merck Sharp & Dohme) by aerosol or injection. The children had a history of receiving MMR at age 1-2 years. The aerosolization was performed through a vibrating mesh nebulizer.
Courtesy CDC/NIP/Barbara Rice
Measles cases has reached a 20-year high in the United States, with 288 reported as of May 23.The persistence of immunity 1 year after the booster vaccination showed 100% seropositivity for measles and rubella and 90.3%-96.6% for mumps. The differences were not statistically significant among the four groups (P = .485).
Aerosolized vaccines are not available in the United States.
Aerosolized MMR vaccine can be used in booster campaigns in school-age children for measles and rubella, said José Luis Díaz Ortega, MD, of the Instituto Nacional de Salud Pública, Mexico, and his associates.
However, more studies of school-age children with longer follow-up of mumps antibody persistence are needed, they said.
CDC/ Cynthia S. Goldsmith; William Bellini, Ph.D.
Measles vironA 1-year serological follow-up study was done in 241 Mexican children aged 6-7 years who received vaccine MMR SII (Serum Institute of India) administered by aerosol or injection or MMR II (Merck Sharp & Dohme) by aerosol or injection. The children had a history of receiving MMR at age 1-2 years. The aerosolization was performed through a vibrating mesh nebulizer.
Courtesy CDC/NIP/Barbara Rice
Measles cases has reached a 20-year high in the United States, with 288 reported as of May 23.The persistence of immunity 1 year after the booster vaccination showed 100% seropositivity for measles and rubella and 90.3%-96.6% for mumps. The differences were not statistically significant among the four groups (P = .485).
Aerosolized vaccines are not available in the United States.
Aerosolized MMR vaccine can be used in booster campaigns in school-age children for measles and rubella, said José Luis Díaz Ortega, MD, of the Instituto Nacional de Salud Pública, Mexico, and his associates.
However, more studies of school-age children with longer follow-up of mumps antibody persistence are needed, they said.
CDC/ Cynthia S. Goldsmith; William Bellini, Ph.D.
Measles vironA 1-year serological follow-up study was done in 241 Mexican children aged 6-7 years who received vaccine MMR SII (Serum Institute of India) administered by aerosol or injection or MMR II (Merck Sharp & Dohme) by aerosol or injection. The children had a history of receiving MMR at age 1-2 years. The aerosolization was performed through a vibrating mesh nebulizer.
Courtesy CDC/NIP/Barbara Rice
Measles cases has reached a 20-year high in the United States, with 288 reported as of May 23.The persistence of immunity 1 year after the booster vaccination showed 100% seropositivity for measles and rubella and 90.3%-96.6% for mumps. The differences were not statistically significant among the four groups (P = .485).
Aerosolized vaccines are not available in the United States.
Robert De Marco, MD, FCCP, was one of the first Champions Circle and Founder’s Society donors to make a major gift through insurance. We thank the De Marco family for their support in championing lung health, and it’s our pleasure to share the highlights of a recent interview with Dr. De Marco.
Why did you choose to give through insurance?
Dr. Robert De MarcoI had a Universal Life Policy that I bought when I was first in practice. While it would be a nice addition to my family bequest, it would be a much better gift to the foundation.
How was the process? Did you know anything about giving through insurance beforehand?
I knew nothing about donating insurance. I heard about it during a board strategy session and realized I had a policy that could be donated. I contacted my insurance company. I was sent forms, which were easy to fill out. The forms were then forwarded to CHEST for some signatures, and it was completed. It could not have been easier.
Would you recommend this method of giving to other donors?
Absolutely. If this policy isn’t vital to your family after you are gone, there could not be a better choice.
Why was this choice right for you and your family?
If you must take a significant amount of money out of your savings to make a sizable donation, you can put a serious dent in your retirement income. To be able to make that gift without any effect on my savings is a win-win for everyone.
Why do you continue to give to the CHEST Foundation?
I have spent my whole career trying to deal with diseases of the chest. What better way to sustain my efforts than to support a foundation dedicated to my life’s dreams? There is nothing more fulfilling than helping fund research or a project that could forever change the future of our patients’ lives. I truly believe we, as a group, are on the right path to succeeding in doing just that.
How is giving to the CHEST Foundation fulfilling to you?
How can any effort that will make the lives of our patients better not be fulfilling? Giving my time and effort without the expectation of something in return is an amazing feeling—one that I hope many donors in the future will realize. Just being a part of this great organization is a phenomenal experience.
GIFTS OF LIFE INSURANCE
Easy Solutions for a Greater Impact
If you own a life insurance policy that is no longer needed for its original purpose, you may consider gifting it to the CHEST Foundation.
You can also create a new policy naming the CHEST Foundation as the owner and beneficiary. An annual gift equal to the insurance premium can be given, which would provide you with a charitable deduction. The foundation would then direct the funds to the insurance provider.
This is an excellent win-win solution for you and the CHEST Foundation. For more information on these and other ways to support the CHEST Foundation, confidentially and with no obligation, contact Rudy Anderson at randerson@chestnet.org or 224/521-9492.
Robert De Marco, MD, FCCP, was one of the first Champions Circle and Founder’s Society donors to make a major gift through insurance. We thank the De Marco family for their support in championing lung health, and it’s our pleasure to share the highlights of a recent interview with Dr. De Marco.
Why did you choose to give through insurance?
Dr. Robert De MarcoI had a Universal Life Policy that I bought when I was first in practice. While it would be a nice addition to my family bequest, it would be a much better gift to the foundation.
How was the process? Did you know anything about giving through insurance beforehand?
I knew nothing about donating insurance. I heard about it during a board strategy session and realized I had a policy that could be donated. I contacted my insurance company. I was sent forms, which were easy to fill out. The forms were then forwarded to CHEST for some signatures, and it was completed. It could not have been easier.
Would you recommend this method of giving to other donors?
Absolutely. If this policy isn’t vital to your family after you are gone, there could not be a better choice.
Why was this choice right for you and your family?
If you must take a significant amount of money out of your savings to make a sizable donation, you can put a serious dent in your retirement income. To be able to make that gift without any effect on my savings is a win-win for everyone.
Why do you continue to give to the CHEST Foundation?
I have spent my whole career trying to deal with diseases of the chest. What better way to sustain my efforts than to support a foundation dedicated to my life’s dreams? There is nothing more fulfilling than helping fund research or a project that could forever change the future of our patients’ lives. I truly believe we, as a group, are on the right path to succeeding in doing just that.
How is giving to the CHEST Foundation fulfilling to you?
How can any effort that will make the lives of our patients better not be fulfilling? Giving my time and effort without the expectation of something in return is an amazing feeling—one that I hope many donors in the future will realize. Just being a part of this great organization is a phenomenal experience.
GIFTS OF LIFE INSURANCE
Easy Solutions for a Greater Impact
If you own a life insurance policy that is no longer needed for its original purpose, you may consider gifting it to the CHEST Foundation.
You can also create a new policy naming the CHEST Foundation as the owner and beneficiary. An annual gift equal to the insurance premium can be given, which would provide you with a charitable deduction. The foundation would then direct the funds to the insurance provider.
This is an excellent win-win solution for you and the CHEST Foundation. For more information on these and other ways to support the CHEST Foundation, confidentially and with no obligation, contact Rudy Anderson at randerson@chestnet.org or 224/521-9492.
Robert De Marco, MD, FCCP, was one of the first Champions Circle and Founder’s Society donors to make a major gift through insurance. We thank the De Marco family for their support in championing lung health, and it’s our pleasure to share the highlights of a recent interview with Dr. De Marco.
Why did you choose to give through insurance?
Dr. Robert De MarcoI had a Universal Life Policy that I bought when I was first in practice. While it would be a nice addition to my family bequest, it would be a much better gift to the foundation.
How was the process? Did you know anything about giving through insurance beforehand?
I knew nothing about donating insurance. I heard about it during a board strategy session and realized I had a policy that could be donated. I contacted my insurance company. I was sent forms, which were easy to fill out. The forms were then forwarded to CHEST for some signatures, and it was completed. It could not have been easier.
Would you recommend this method of giving to other donors?
Absolutely. If this policy isn’t vital to your family after you are gone, there could not be a better choice.
Why was this choice right for you and your family?
If you must take a significant amount of money out of your savings to make a sizable donation, you can put a serious dent in your retirement income. To be able to make that gift without any effect on my savings is a win-win for everyone.
Why do you continue to give to the CHEST Foundation?
I have spent my whole career trying to deal with diseases of the chest. What better way to sustain my efforts than to support a foundation dedicated to my life’s dreams? There is nothing more fulfilling than helping fund research or a project that could forever change the future of our patients’ lives. I truly believe we, as a group, are on the right path to succeeding in doing just that.
How is giving to the CHEST Foundation fulfilling to you?
How can any effort that will make the lives of our patients better not be fulfilling? Giving my time and effort without the expectation of something in return is an amazing feeling—one that I hope many donors in the future will realize. Just being a part of this great organization is a phenomenal experience.
GIFTS OF LIFE INSURANCE
Easy Solutions for a Greater Impact
If you own a life insurance policy that is no longer needed for its original purpose, you may consider gifting it to the CHEST Foundation.
You can also create a new policy naming the CHEST Foundation as the owner and beneficiary. An annual gift equal to the insurance premium can be given, which would provide you with a charitable deduction. The foundation would then direct the funds to the insurance provider.
This is an excellent win-win solution for you and the CHEST Foundation. For more information on these and other ways to support the CHEST Foundation, confidentially and with no obligation, contact Rudy Anderson at randerson@chestnet.org or 224/521-9492.
Drs. Simpson, Hogarth, and Moores told Reddit to ask them anything—here’s what happened next.
“Is there an organ or system that sepsis generally targets?”
“If I’m going to be in the back of a cramped car cross country for 16 hours straight, should I take an aspirin beforehand to cut down risk of DVT?”
“Hello Doctor. Does thermoplasty have any application for bronchiectasis patients, like myself?”
Dr. Kyle HogarthReddit is a social news aggregation site allowing users to post a wide range of topics to create discussion. The platform is currently one of the most informative and popular social sites on the web and has a huge following of members who focus their discussions on health care/science.
Within the science AMA subsection, users have the ability to post a topic or questions about anything and respond to other users. AMA, which stands for “Ask Me Anything,” describes the conversation happening between the user and the host of the topic. Users have the ability to ask questions related to the topic, or even ‘upvote’ particular questions that they would like answered. An ‘upvote’ moves a question or comment to the top of the page to become more visible to the host. AMAs can become trending topics on Reddit through ‘upvotes’, as well.
In an effort to help educate and inform individuals on advancements in chest medicine education, clinical research, and team-based care, CHEST has connected specialists with a deep passion for topics in pulmonary, critical care, and sleep medicine to an audience filled with questions ready to be answered. Some of the topics we’ve covered include:
Sepsis with Dr. Steven Q. Simpson, FCCP, who is a pulmonologist, intensivist, CHEST board member, and a sepsis researcher and expert. Dr. Simpson discussed the recent consensus statement on sepsis diagnosis. The statement aimed to redefine the diagnostic criteria of sepsis and eliminate the concept of the systemic inflammatory response syndrome (SIRS). Dr. Simpson shared his rebuttal New Sepsis Guidelines: A Change We Should Not Make in the journal CHEST. Dr. Simpson’s statement expressed the concern that widespread application of this new SIRS definition could cost patient lives, and it should not be adopted. This AMA was upvoted 784 times.
Asthma and bronchial thermoplasty with Dr. D. Kyle Hogarth, FCCP, who is a pulmonologist, member of CHEST, and the first physician in Illinois to perform bronchial thermoplasty, a nonpharmaceutical treatment for severe asthma. This AMA was upvoted 3,112 times.
DVT with Dr. Lisa K. Moores, FCCP, who is a pulmonologist, member of CHEST, and an expert on thrombosis. Dr. Moores discussed VTE, DVT, and PE. This AMA was upvoted 903 times.
Hosting Reddit AMAs has allowed CHEST to not only reach a more public-facing audience but also health-care providers outside of chest medicine. Stepping into this platform has allowed us to position CHEST as a subject matter expert in topics like asthma, sepsis, and DVT/VTE. These AMAs have helped people to understand the role our members play within health-care by showcasing new and emerging treatments and raising public awareness of health conditions.
If you are interested in sharing your knowledge on a specific topic on Reddit, you can contact CHEST’s New Media Specialist Taylor Pecko-Reid, at tpeckoreid@chestnet.org.
Drs. Simpson, Hogarth, and Moores told Reddit to ask them anything—here’s what happened next.
“Is there an organ or system that sepsis generally targets?”
“If I’m going to be in the back of a cramped car cross country for 16 hours straight, should I take an aspirin beforehand to cut down risk of DVT?”
“Hello Doctor. Does thermoplasty have any application for bronchiectasis patients, like myself?”
Dr. Kyle HogarthReddit is a social news aggregation site allowing users to post a wide range of topics to create discussion. The platform is currently one of the most informative and popular social sites on the web and has a huge following of members who focus their discussions on health care/science.
Within the science AMA subsection, users have the ability to post a topic or questions about anything and respond to other users. AMA, which stands for “Ask Me Anything,” describes the conversation happening between the user and the host of the topic. Users have the ability to ask questions related to the topic, or even ‘upvote’ particular questions that they would like answered. An ‘upvote’ moves a question or comment to the top of the page to become more visible to the host. AMAs can become trending topics on Reddit through ‘upvotes’, as well.
In an effort to help educate and inform individuals on advancements in chest medicine education, clinical research, and team-based care, CHEST has connected specialists with a deep passion for topics in pulmonary, critical care, and sleep medicine to an audience filled with questions ready to be answered. Some of the topics we’ve covered include:
Sepsis with Dr. Steven Q. Simpson, FCCP, who is a pulmonologist, intensivist, CHEST board member, and a sepsis researcher and expert. Dr. Simpson discussed the recent consensus statement on sepsis diagnosis. The statement aimed to redefine the diagnostic criteria of sepsis and eliminate the concept of the systemic inflammatory response syndrome (SIRS). Dr. Simpson shared his rebuttal New Sepsis Guidelines: A Change We Should Not Make in the journal CHEST. Dr. Simpson’s statement expressed the concern that widespread application of this new SIRS definition could cost patient lives, and it should not be adopted. This AMA was upvoted 784 times.
Asthma and bronchial thermoplasty with Dr. D. Kyle Hogarth, FCCP, who is a pulmonologist, member of CHEST, and the first physician in Illinois to perform bronchial thermoplasty, a nonpharmaceutical treatment for severe asthma. This AMA was upvoted 3,112 times.
DVT with Dr. Lisa K. Moores, FCCP, who is a pulmonologist, member of CHEST, and an expert on thrombosis. Dr. Moores discussed VTE, DVT, and PE. This AMA was upvoted 903 times.
Hosting Reddit AMAs has allowed CHEST to not only reach a more public-facing audience but also health-care providers outside of chest medicine. Stepping into this platform has allowed us to position CHEST as a subject matter expert in topics like asthma, sepsis, and DVT/VTE. These AMAs have helped people to understand the role our members play within health-care by showcasing new and emerging treatments and raising public awareness of health conditions.
If you are interested in sharing your knowledge on a specific topic on Reddit, you can contact CHEST’s New Media Specialist Taylor Pecko-Reid, at tpeckoreid@chestnet.org.
Drs. Simpson, Hogarth, and Moores told Reddit to ask them anything—here’s what happened next.
“Is there an organ or system that sepsis generally targets?”
“If I’m going to be in the back of a cramped car cross country for 16 hours straight, should I take an aspirin beforehand to cut down risk of DVT?”
“Hello Doctor. Does thermoplasty have any application for bronchiectasis patients, like myself?”
Dr. Kyle HogarthReddit is a social news aggregation site allowing users to post a wide range of topics to create discussion. The platform is currently one of the most informative and popular social sites on the web and has a huge following of members who focus their discussions on health care/science.
Within the science AMA subsection, users have the ability to post a topic or questions about anything and respond to other users. AMA, which stands for “Ask Me Anything,” describes the conversation happening between the user and the host of the topic. Users have the ability to ask questions related to the topic, or even ‘upvote’ particular questions that they would like answered. An ‘upvote’ moves a question or comment to the top of the page to become more visible to the host. AMAs can become trending topics on Reddit through ‘upvotes’, as well.
In an effort to help educate and inform individuals on advancements in chest medicine education, clinical research, and team-based care, CHEST has connected specialists with a deep passion for topics in pulmonary, critical care, and sleep medicine to an audience filled with questions ready to be answered. Some of the topics we’ve covered include:
Sepsis with Dr. Steven Q. Simpson, FCCP, who is a pulmonologist, intensivist, CHEST board member, and a sepsis researcher and expert. Dr. Simpson discussed the recent consensus statement on sepsis diagnosis. The statement aimed to redefine the diagnostic criteria of sepsis and eliminate the concept of the systemic inflammatory response syndrome (SIRS). Dr. Simpson shared his rebuttal New Sepsis Guidelines: A Change We Should Not Make in the journal CHEST. Dr. Simpson’s statement expressed the concern that widespread application of this new SIRS definition could cost patient lives, and it should not be adopted. This AMA was upvoted 784 times.
Asthma and bronchial thermoplasty with Dr. D. Kyle Hogarth, FCCP, who is a pulmonologist, member of CHEST, and the first physician in Illinois to perform bronchial thermoplasty, a nonpharmaceutical treatment for severe asthma. This AMA was upvoted 3,112 times.
DVT with Dr. Lisa K. Moores, FCCP, who is a pulmonologist, member of CHEST, and an expert on thrombosis. Dr. Moores discussed VTE, DVT, and PE. This AMA was upvoted 903 times.
Hosting Reddit AMAs has allowed CHEST to not only reach a more public-facing audience but also health-care providers outside of chest medicine. Stepping into this platform has allowed us to position CHEST as a subject matter expert in topics like asthma, sepsis, and DVT/VTE. These AMAs have helped people to understand the role our members play within health-care by showcasing new and emerging treatments and raising public awareness of health conditions.
If you are interested in sharing your knowledge on a specific topic on Reddit, you can contact CHEST’s New Media Specialist Taylor Pecko-Reid, at tpeckoreid@chestnet.org.
The Board of Regents of the American College of Chest Physicians (CHEST) has finalized the appointment of Stephen J. Welch as Executive Vice President and Chief Executive Officer for CHEST. Welch had been serving as the interim EVP/CEO since May 2016. Prior to this appointment, he served in a senior staff role at CHEST for 22 years, most recently as Publisher and Senior Vice President of Publications and Digital Content, which includes managing the organization’s flagship scientific journal, CHEST®.
Dr. Stephen Welch“We appreciate the exceptional performance of Steve, his senior team, and the entire CHEST staff during this transition in executive leadership. We are excited about the opportunity to work with Steve in his new role going forward, as we begin outlining CHEST’s strategic plan for the next 5 years,” said CHEST President Gerard A. Silvestri, MD, MS, FCCP.
In response to the announcement, Steve remarked, “I am sincerely humbled and honored to have this opportunity and am excited for the future of CHEST, a dynamic, innovative organization that is doing great things, and we will continue our track record of excellent performance.”
The Board of Regents of the American College of Chest Physicians (CHEST) has finalized the appointment of Stephen J. Welch as Executive Vice President and Chief Executive Officer for CHEST. Welch had been serving as the interim EVP/CEO since May 2016. Prior to this appointment, he served in a senior staff role at CHEST for 22 years, most recently as Publisher and Senior Vice President of Publications and Digital Content, which includes managing the organization’s flagship scientific journal, CHEST®.
Dr. Stephen Welch“We appreciate the exceptional performance of Steve, his senior team, and the entire CHEST staff during this transition in executive leadership. We are excited about the opportunity to work with Steve in his new role going forward, as we begin outlining CHEST’s strategic plan for the next 5 years,” said CHEST President Gerard A. Silvestri, MD, MS, FCCP.
In response to the announcement, Steve remarked, “I am sincerely humbled and honored to have this opportunity and am excited for the future of CHEST, a dynamic, innovative organization that is doing great things, and we will continue our track record of excellent performance.”
The Board of Regents of the American College of Chest Physicians (CHEST) has finalized the appointment of Stephen J. Welch as Executive Vice President and Chief Executive Officer for CHEST. Welch had been serving as the interim EVP/CEO since May 2016. Prior to this appointment, he served in a senior staff role at CHEST for 22 years, most recently as Publisher and Senior Vice President of Publications and Digital Content, which includes managing the organization’s flagship scientific journal, CHEST®.
Dr. Stephen Welch“We appreciate the exceptional performance of Steve, his senior team, and the entire CHEST staff during this transition in executive leadership. We are excited about the opportunity to work with Steve in his new role going forward, as we begin outlining CHEST’s strategic plan for the next 5 years,” said CHEST President Gerard A. Silvestri, MD, MS, FCCP.
In response to the announcement, Steve remarked, “I am sincerely humbled and honored to have this opportunity and am excited for the future of CHEST, a dynamic, innovative organization that is doing great things, and we will continue our track record of excellent performance.”
Explore the talent of Canadian artists and the culture of Toronto during CHEST Annual Meeting 2017.
Over the last decade, Toronto’s art scene has moved to the former industrial district, creating a new home for galleries, especially those of contemporary art. While Toronto’s galleries may not be very busy outside of opening nights, they allow you to visit at any time and admire the artwork at your own pace. Along with art galleries, there are many options available to experience music and performance art, as well as family-friendly activities. Here are a few places you’ll want to visit:
Art Galleries
The Power Plant (4-minute drive), one of Toronto’s most established contemporary art galleries, is located within Harbourfront in an actual power plant - one that was in operation for most of the 1900s. If you’re with young family members, a free, hands-on art workshop led by artists with activities designed around the current exhibitions is available called Power Plant: Power Kids.
Art Metropole (15-minute drive) is a nonprofit organization with an eclectic collection of merchandise, including a huge selection of artist-created books, periodicals,
By Raysonho @ Open Grid Scheduler / Grid Engine (Own work)
Harbourfront Centreposters, clothing, audio, video, and more. The name is taken from the building’s original tenant, Art Metropole, which operated as one of Toronto’s earliest galleries from 1911 to the 1940s. Art Metropole has always been the leader of Toronto’s artistic community. In 1997, over 13,000 items were transferred to the National Gallery of Canada as the “Art Metropole Collection.” The works of world-renowned artists, such as Yoko Ono, Sol Lewitt, Joseph Beuys, and Marcel Duchamp, are included in the collection.
Daniel Faria Gallery (18-minute drive) is a bright contemporary art space found in a warehouse that used to be an auto body shop. A number of reputable, mostly Canadian, artists’ works are displayed by owner Daniel Faria, including works by Shannon Bool, Chris Curreri, Kristine Moran, and Coupland. Check out other neighboring galleries within walking distance, including Tomorrow Gallery and the artist-run Mercer Union.
Music and Theatre
The Rex Jazz & Blues Bar (6-minute drive) has two to three (mostly free) shows every day, about 19 shows a week, jazz jams on Tuesdays, local and international talent, and a fantastic location. This place is truly hard to beat.
Spend an evening at the Canadian Opera Company (6-minute drive). During the week of CHEST 2017, the COC will be showing The Elixir of Love, a Cinderella story presented with a twist, as a poor and uneducated young man dreams ofwinning the heart of a rich, clever, and beautiful woman.
For a wide variety of events and visual art, visit the Harbourfront Centre (4-minute drive). During your time at CHEST 2017, you’ll find options for literary arts, like the International Festival of Authors, theatre, music, shopping, and more. You may even get a chance for family skating on the Natrel Rink, which opens in November!
Note: all estimated times assume you are starting at the Metro Toronto Convention Centre.The arts and culture of Toronto are sure to inspire you, as will CHEST 2017. When you visit Toronto, October 28 to November 1, you’ll have access to cutting-edge education on pulmonary, critical care, and sleep medicine topics.
Learn more, and register today at chestmeeting.chestnet.org.
Explore the talent of Canadian artists and the culture of Toronto during CHEST Annual Meeting 2017.
Over the last decade, Toronto’s art scene has moved to the former industrial district, creating a new home for galleries, especially those of contemporary art. While Toronto’s galleries may not be very busy outside of opening nights, they allow you to visit at any time and admire the artwork at your own pace. Along with art galleries, there are many options available to experience music and performance art, as well as family-friendly activities. Here are a few places you’ll want to visit:
Art Galleries
The Power Plant (4-minute drive), one of Toronto’s most established contemporary art galleries, is located within Harbourfront in an actual power plant - one that was in operation for most of the 1900s. If you’re with young family members, a free, hands-on art workshop led by artists with activities designed around the current exhibitions is available called Power Plant: Power Kids.
Art Metropole (15-minute drive) is a nonprofit organization with an eclectic collection of merchandise, including a huge selection of artist-created books, periodicals,
By Raysonho @ Open Grid Scheduler / Grid Engine (Own work)
Harbourfront Centreposters, clothing, audio, video, and more. The name is taken from the building’s original tenant, Art Metropole, which operated as one of Toronto’s earliest galleries from 1911 to the 1940s. Art Metropole has always been the leader of Toronto’s artistic community. In 1997, over 13,000 items were transferred to the National Gallery of Canada as the “Art Metropole Collection.” The works of world-renowned artists, such as Yoko Ono, Sol Lewitt, Joseph Beuys, and Marcel Duchamp, are included in the collection.
Daniel Faria Gallery (18-minute drive) is a bright contemporary art space found in a warehouse that used to be an auto body shop. A number of reputable, mostly Canadian, artists’ works are displayed by owner Daniel Faria, including works by Shannon Bool, Chris Curreri, Kristine Moran, and Coupland. Check out other neighboring galleries within walking distance, including Tomorrow Gallery and the artist-run Mercer Union.
Music and Theatre
The Rex Jazz & Blues Bar (6-minute drive) has two to three (mostly free) shows every day, about 19 shows a week, jazz jams on Tuesdays, local and international talent, and a fantastic location. This place is truly hard to beat.
Spend an evening at the Canadian Opera Company (6-minute drive). During the week of CHEST 2017, the COC will be showing The Elixir of Love, a Cinderella story presented with a twist, as a poor and uneducated young man dreams ofwinning the heart of a rich, clever, and beautiful woman.
For a wide variety of events and visual art, visit the Harbourfront Centre (4-minute drive). During your time at CHEST 2017, you’ll find options for literary arts, like the International Festival of Authors, theatre, music, shopping, and more. You may even get a chance for family skating on the Natrel Rink, which opens in November!
Note: all estimated times assume you are starting at the Metro Toronto Convention Centre.The arts and culture of Toronto are sure to inspire you, as will CHEST 2017. When you visit Toronto, October 28 to November 1, you’ll have access to cutting-edge education on pulmonary, critical care, and sleep medicine topics.
Learn more, and register today at chestmeeting.chestnet.org.
Explore the talent of Canadian artists and the culture of Toronto during CHEST Annual Meeting 2017.
Over the last decade, Toronto’s art scene has moved to the former industrial district, creating a new home for galleries, especially those of contemporary art. While Toronto’s galleries may not be very busy outside of opening nights, they allow you to visit at any time and admire the artwork at your own pace. Along with art galleries, there are many options available to experience music and performance art, as well as family-friendly activities. Here are a few places you’ll want to visit:
Art Galleries
The Power Plant (4-minute drive), one of Toronto’s most established contemporary art galleries, is located within Harbourfront in an actual power plant - one that was in operation for most of the 1900s. If you’re with young family members, a free, hands-on art workshop led by artists with activities designed around the current exhibitions is available called Power Plant: Power Kids.
Art Metropole (15-minute drive) is a nonprofit organization with an eclectic collection of merchandise, including a huge selection of artist-created books, periodicals,
By Raysonho @ Open Grid Scheduler / Grid Engine (Own work)
Harbourfront Centreposters, clothing, audio, video, and more. The name is taken from the building’s original tenant, Art Metropole, which operated as one of Toronto’s earliest galleries from 1911 to the 1940s. Art Metropole has always been the leader of Toronto’s artistic community. In 1997, over 13,000 items were transferred to the National Gallery of Canada as the “Art Metropole Collection.” The works of world-renowned artists, such as Yoko Ono, Sol Lewitt, Joseph Beuys, and Marcel Duchamp, are included in the collection.
Daniel Faria Gallery (18-minute drive) is a bright contemporary art space found in a warehouse that used to be an auto body shop. A number of reputable, mostly Canadian, artists’ works are displayed by owner Daniel Faria, including works by Shannon Bool, Chris Curreri, Kristine Moran, and Coupland. Check out other neighboring galleries within walking distance, including Tomorrow Gallery and the artist-run Mercer Union.
Music and Theatre
The Rex Jazz & Blues Bar (6-minute drive) has two to three (mostly free) shows every day, about 19 shows a week, jazz jams on Tuesdays, local and international talent, and a fantastic location. This place is truly hard to beat.
Spend an evening at the Canadian Opera Company (6-minute drive). During the week of CHEST 2017, the COC will be showing The Elixir of Love, a Cinderella story presented with a twist, as a poor and uneducated young man dreams ofwinning the heart of a rich, clever, and beautiful woman.
For a wide variety of events and visual art, visit the Harbourfront Centre (4-minute drive). During your time at CHEST 2017, you’ll find options for literary arts, like the International Festival of Authors, theatre, music, shopping, and more. You may even get a chance for family skating on the Natrel Rink, which opens in November!
Note: all estimated times assume you are starting at the Metro Toronto Convention Centre.The arts and culture of Toronto are sure to inspire you, as will CHEST 2017. When you visit Toronto, October 28 to November 1, you’ll have access to cutting-edge education on pulmonary, critical care, and sleep medicine topics.
Learn more, and register today at chestmeeting.chestnet.org.
Down syndrome (DS) is the most common chromosomal disorder with an estimated 250,700 children, teens, and adults living with DS in the United States in 2008 (CDC.gov). The life expectancy for individuals with DS has increased due to improved medical care, educational interventions, and identification and management of underlying psychiatric and behavioral problems. This has resulted in increased median age to 49 years, and the life expectancy of a 1-year-old child with DS to more than 60 to 65 years (Bittles et al. Dev Med Child Neurol. 2004;46[4]:282).
Sleep medicine specialists have been very involved in the care of the pediatric DS population but with the improved survival, more adult patients with DS are presenting to sleep clinics for their care. The complexity of caring for adult patients with DS poses a challenge to sleep specialists, especially with the paucity of literature and clinical guidelines.
Dr. Fidaa ShaibOSA is more prevalent in children with DS (30% to 55%) compared with control subjects (2%). This high OSA prevalence further increases to 90% in adults with DS and is associated with more oxygen desaturation, hypoventilation, and sleep disruption (Trois et al. J Clin Sleep Med. 2009;5[4]:317). Childhood risk factors for OSA in DS are mostly related to hypotonia, relatively large tongue, tonsillar and adenoid hypertrophy, and the small airway. Obesity, hypothyroidism, and, more importantly, advancing age contribute to the increased risk of OSA in adults with DS. Central sleep apnea is relatively rare in adults with DS (Esbensen. Int Rev Res Ment Retard. 2010;39(C):107).
A bidirectional relationship exists between sleep disorders and mood and cognitive problems in this population. The frequency of OSA diagnosis is increased in adults with DS who present with new-onset mood disorder or declining adaptive skills (Capone et al. Am J Med Genet A. 2013;161A[9]:2188). OSA in DS is associated with sleep disruption, decreased slow wave sleep, and intermittent hypoxemia that are thought to contribute to the mechanism of declining cognitive function and memory. Given that individuals with DS are genetically at increased risk for diffuse senile plaque formation in the brain (a characteristic pathologic finding in Alzheimer’s disease brain), the super-imposed sleep fragmentation and intermittent hypoxia may accelerate the cognitive decline (Fernandez et al. J Alzheimers Dis Parkinsonism. 2013;3[2]:124).
In addition, sleep in adults with DS is characterized by a high incidence of sleep fragmentation and circadian misalignment with delayed sleep onset and early morning awakenings (Esbensen. J Intellect Disabil Res. 2016;60[1]:68). The DS population is also at increased risk for developing depression, anxiety, obsessive-compulsive tendencies, and behavioral issues. It is also worth noting that there is a tenfold increase in autism spectrum disease in this population, and a rare condition of developmental regression in adolescents with DS has recently been recognized. Patients usually present with rapid, atypical loss of previously attained skills in cognition, socialization, and activities of daily living that may further complicate their care. The regression occurs with maladaptive behaviors that develop in relation to new transitions, hormonal or menstrual changes, or major life events (Jensen et al. Br Med J. 2014;349:g5596). As a result, new behavioral sleep problems may emerge, or challenges to the treatment of existing sleep disorders may ensue. All of the aforementioned conditions alone or in combination pose additional challenges for the management of sleep problems in this population.
Adults with DS continue to manifest the same spectrum of health problems as children with DS. Adults with DS also tend toward premature aging, which puts them at risk for additional health problems seen in the geriatric population (Covelli et al. Int J Rehabil Res. 2016;39[1]:20). Adults with DS will age earlier and two times faster than control subjects (Nakamura et al. Mech Ageing Dev. 1998;05:89). Coexisting obesity and worsening cognitive function that further increase after the age of 40 will make multiple aspects of medical management very challenging (Carfi et al. Front Med. 2014;1:51).
The care of the adult patient with DS can be best delivered through a multidisciplinary team, led by physicians well informed about the specific needs of this population. The role of the sleep specialist is essential, given the implications of sleep on health and cognitive and behavioral function. The approach to diagnosing disorders of sleep timing, quality, and duration includes a focused history. Incorporating actigraphic monitoring provides additional information that can be relevant and useful. The value of the parent-reported sleep diary becomes less and less reliable as patients enter adolescence and adulthood. Attended sleep studies are widely utilized for diagnosing sleep-disordered breathing, but their value in guiding therapy is debatable. There are multiple factors that can affect the validity of a single night of sleep testing for the individual patient. Such factors include poor sleep achieved in a strange environment and sleep position variations when compared with sleep at home. There is no evidence yet to support the use of portable sleep testing in this population.
Establishing and maintaining routines are critical in different aspects of the care of this special population, particularly in relation to behavioral sleep problems. Success is dependent on the caregiver’s approach and level of involvement in their care, the individual’s intellectual ability, and the presence of other comorbidities. Management of obesity with counseling on healthy diet and participation in exercise programs are also integral parts of their care.
Although treatment with positive airway pressure (PAP) is thought to be effective in treating OSA in DS, little data are available to support its efficacy and benefits. Treatment of OSA with PAP can be very challenging. Our sleep center experience incorporates a personalized approach with gradual PAP desensitization in addition to positive feedback and a reward system to encourage and maintain use. We also utilize behavioral therapy to encourage avoidance of supine sleep in order to decrease the severity of OSA in patients who do not accept or tolerate PAP. Surgical interventions based on assessment of the upper airway during sleep through dynamic imaging or sleep endoscopy may also be considered. A recent report of hypoglossal nerve stimulation therapy in an adolescent with severe OSA suggests a potentially new alternative option for therapy (Diercks et al. Pediatrics. 2016;137(5). doi: 10.1542/peds.2015-3663.
It seems intuitive that the management of sleep disorders in adult patients with DS positively contributes to their care and promotes their overall wellbeing. Adult patients with DS continue to present particular diagnostic and therapeutic challenges that have become even more complex as their life expectancy has increased. Further research and clinical guidelines are momentously needed in order to guide the management of sleep disorders for this particularly challenging patient population.
Dr. Shaib is Associate Professor of Medicine, Medical Director, Baylor St Luke’s Center for Sleep Medicine, Department of Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, Texas.
Down syndrome (DS) is the most common chromosomal disorder with an estimated 250,700 children, teens, and adults living with DS in the United States in 2008 (CDC.gov). The life expectancy for individuals with DS has increased due to improved medical care, educational interventions, and identification and management of underlying psychiatric and behavioral problems. This has resulted in increased median age to 49 years, and the life expectancy of a 1-year-old child with DS to more than 60 to 65 years (Bittles et al. Dev Med Child Neurol. 2004;46[4]:282).
Sleep medicine specialists have been very involved in the care of the pediatric DS population but with the improved survival, more adult patients with DS are presenting to sleep clinics for their care. The complexity of caring for adult patients with DS poses a challenge to sleep specialists, especially with the paucity of literature and clinical guidelines.
Dr. Fidaa ShaibOSA is more prevalent in children with DS (30% to 55%) compared with control subjects (2%). This high OSA prevalence further increases to 90% in adults with DS and is associated with more oxygen desaturation, hypoventilation, and sleep disruption (Trois et al. J Clin Sleep Med. 2009;5[4]:317). Childhood risk factors for OSA in DS are mostly related to hypotonia, relatively large tongue, tonsillar and adenoid hypertrophy, and the small airway. Obesity, hypothyroidism, and, more importantly, advancing age contribute to the increased risk of OSA in adults with DS. Central sleep apnea is relatively rare in adults with DS (Esbensen. Int Rev Res Ment Retard. 2010;39(C):107).
A bidirectional relationship exists between sleep disorders and mood and cognitive problems in this population. The frequency of OSA diagnosis is increased in adults with DS who present with new-onset mood disorder or declining adaptive skills (Capone et al. Am J Med Genet A. 2013;161A[9]:2188). OSA in DS is associated with sleep disruption, decreased slow wave sleep, and intermittent hypoxemia that are thought to contribute to the mechanism of declining cognitive function and memory. Given that individuals with DS are genetically at increased risk for diffuse senile plaque formation in the brain (a characteristic pathologic finding in Alzheimer’s disease brain), the super-imposed sleep fragmentation and intermittent hypoxia may accelerate the cognitive decline (Fernandez et al. J Alzheimers Dis Parkinsonism. 2013;3[2]:124).
In addition, sleep in adults with DS is characterized by a high incidence of sleep fragmentation and circadian misalignment with delayed sleep onset and early morning awakenings (Esbensen. J Intellect Disabil Res. 2016;60[1]:68). The DS population is also at increased risk for developing depression, anxiety, obsessive-compulsive tendencies, and behavioral issues. It is also worth noting that there is a tenfold increase in autism spectrum disease in this population, and a rare condition of developmental regression in adolescents with DS has recently been recognized. Patients usually present with rapid, atypical loss of previously attained skills in cognition, socialization, and activities of daily living that may further complicate their care. The regression occurs with maladaptive behaviors that develop in relation to new transitions, hormonal or menstrual changes, or major life events (Jensen et al. Br Med J. 2014;349:g5596). As a result, new behavioral sleep problems may emerge, or challenges to the treatment of existing sleep disorders may ensue. All of the aforementioned conditions alone or in combination pose additional challenges for the management of sleep problems in this population.
Adults with DS continue to manifest the same spectrum of health problems as children with DS. Adults with DS also tend toward premature aging, which puts them at risk for additional health problems seen in the geriatric population (Covelli et al. Int J Rehabil Res. 2016;39[1]:20). Adults with DS will age earlier and two times faster than control subjects (Nakamura et al. Mech Ageing Dev. 1998;05:89). Coexisting obesity and worsening cognitive function that further increase after the age of 40 will make multiple aspects of medical management very challenging (Carfi et al. Front Med. 2014;1:51).
The care of the adult patient with DS can be best delivered through a multidisciplinary team, led by physicians well informed about the specific needs of this population. The role of the sleep specialist is essential, given the implications of sleep on health and cognitive and behavioral function. The approach to diagnosing disorders of sleep timing, quality, and duration includes a focused history. Incorporating actigraphic monitoring provides additional information that can be relevant and useful. The value of the parent-reported sleep diary becomes less and less reliable as patients enter adolescence and adulthood. Attended sleep studies are widely utilized for diagnosing sleep-disordered breathing, but their value in guiding therapy is debatable. There are multiple factors that can affect the validity of a single night of sleep testing for the individual patient. Such factors include poor sleep achieved in a strange environment and sleep position variations when compared with sleep at home. There is no evidence yet to support the use of portable sleep testing in this population.
Establishing and maintaining routines are critical in different aspects of the care of this special population, particularly in relation to behavioral sleep problems. Success is dependent on the caregiver’s approach and level of involvement in their care, the individual’s intellectual ability, and the presence of other comorbidities. Management of obesity with counseling on healthy diet and participation in exercise programs are also integral parts of their care.
Although treatment with positive airway pressure (PAP) is thought to be effective in treating OSA in DS, little data are available to support its efficacy and benefits. Treatment of OSA with PAP can be very challenging. Our sleep center experience incorporates a personalized approach with gradual PAP desensitization in addition to positive feedback and a reward system to encourage and maintain use. We also utilize behavioral therapy to encourage avoidance of supine sleep in order to decrease the severity of OSA in patients who do not accept or tolerate PAP. Surgical interventions based on assessment of the upper airway during sleep through dynamic imaging or sleep endoscopy may also be considered. A recent report of hypoglossal nerve stimulation therapy in an adolescent with severe OSA suggests a potentially new alternative option for therapy (Diercks et al. Pediatrics. 2016;137(5). doi: 10.1542/peds.2015-3663.
It seems intuitive that the management of sleep disorders in adult patients with DS positively contributes to their care and promotes their overall wellbeing. Adult patients with DS continue to present particular diagnostic and therapeutic challenges that have become even more complex as their life expectancy has increased. Further research and clinical guidelines are momentously needed in order to guide the management of sleep disorders for this particularly challenging patient population.
Dr. Shaib is Associate Professor of Medicine, Medical Director, Baylor St Luke’s Center for Sleep Medicine, Department of Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, Texas.
Down syndrome (DS) is the most common chromosomal disorder with an estimated 250,700 children, teens, and adults living with DS in the United States in 2008 (CDC.gov). The life expectancy for individuals with DS has increased due to improved medical care, educational interventions, and identification and management of underlying psychiatric and behavioral problems. This has resulted in increased median age to 49 years, and the life expectancy of a 1-year-old child with DS to more than 60 to 65 years (Bittles et al. Dev Med Child Neurol. 2004;46[4]:282).
Sleep medicine specialists have been very involved in the care of the pediatric DS population but with the improved survival, more adult patients with DS are presenting to sleep clinics for their care. The complexity of caring for adult patients with DS poses a challenge to sleep specialists, especially with the paucity of literature and clinical guidelines.
Dr. Fidaa ShaibOSA is more prevalent in children with DS (30% to 55%) compared with control subjects (2%). This high OSA prevalence further increases to 90% in adults with DS and is associated with more oxygen desaturation, hypoventilation, and sleep disruption (Trois et al. J Clin Sleep Med. 2009;5[4]:317). Childhood risk factors for OSA in DS are mostly related to hypotonia, relatively large tongue, tonsillar and adenoid hypertrophy, and the small airway. Obesity, hypothyroidism, and, more importantly, advancing age contribute to the increased risk of OSA in adults with DS. Central sleep apnea is relatively rare in adults with DS (Esbensen. Int Rev Res Ment Retard. 2010;39(C):107).
A bidirectional relationship exists between sleep disorders and mood and cognitive problems in this population. The frequency of OSA diagnosis is increased in adults with DS who present with new-onset mood disorder or declining adaptive skills (Capone et al. Am J Med Genet A. 2013;161A[9]:2188). OSA in DS is associated with sleep disruption, decreased slow wave sleep, and intermittent hypoxemia that are thought to contribute to the mechanism of declining cognitive function and memory. Given that individuals with DS are genetically at increased risk for diffuse senile plaque formation in the brain (a characteristic pathologic finding in Alzheimer’s disease brain), the super-imposed sleep fragmentation and intermittent hypoxia may accelerate the cognitive decline (Fernandez et al. J Alzheimers Dis Parkinsonism. 2013;3[2]:124).
In addition, sleep in adults with DS is characterized by a high incidence of sleep fragmentation and circadian misalignment with delayed sleep onset and early morning awakenings (Esbensen. J Intellect Disabil Res. 2016;60[1]:68). The DS population is also at increased risk for developing depression, anxiety, obsessive-compulsive tendencies, and behavioral issues. It is also worth noting that there is a tenfold increase in autism spectrum disease in this population, and a rare condition of developmental regression in adolescents with DS has recently been recognized. Patients usually present with rapid, atypical loss of previously attained skills in cognition, socialization, and activities of daily living that may further complicate their care. The regression occurs with maladaptive behaviors that develop in relation to new transitions, hormonal or menstrual changes, or major life events (Jensen et al. Br Med J. 2014;349:g5596). As a result, new behavioral sleep problems may emerge, or challenges to the treatment of existing sleep disorders may ensue. All of the aforementioned conditions alone or in combination pose additional challenges for the management of sleep problems in this population.
Adults with DS continue to manifest the same spectrum of health problems as children with DS. Adults with DS also tend toward premature aging, which puts them at risk for additional health problems seen in the geriatric population (Covelli et al. Int J Rehabil Res. 2016;39[1]:20). Adults with DS will age earlier and two times faster than control subjects (Nakamura et al. Mech Ageing Dev. 1998;05:89). Coexisting obesity and worsening cognitive function that further increase after the age of 40 will make multiple aspects of medical management very challenging (Carfi et al. Front Med. 2014;1:51).
The care of the adult patient with DS can be best delivered through a multidisciplinary team, led by physicians well informed about the specific needs of this population. The role of the sleep specialist is essential, given the implications of sleep on health and cognitive and behavioral function. The approach to diagnosing disorders of sleep timing, quality, and duration includes a focused history. Incorporating actigraphic monitoring provides additional information that can be relevant and useful. The value of the parent-reported sleep diary becomes less and less reliable as patients enter adolescence and adulthood. Attended sleep studies are widely utilized for diagnosing sleep-disordered breathing, but their value in guiding therapy is debatable. There are multiple factors that can affect the validity of a single night of sleep testing for the individual patient. Such factors include poor sleep achieved in a strange environment and sleep position variations when compared with sleep at home. There is no evidence yet to support the use of portable sleep testing in this population.
Establishing and maintaining routines are critical in different aspects of the care of this special population, particularly in relation to behavioral sleep problems. Success is dependent on the caregiver’s approach and level of involvement in their care, the individual’s intellectual ability, and the presence of other comorbidities. Management of obesity with counseling on healthy diet and participation in exercise programs are also integral parts of their care.
Although treatment with positive airway pressure (PAP) is thought to be effective in treating OSA in DS, little data are available to support its efficacy and benefits. Treatment of OSA with PAP can be very challenging. Our sleep center experience incorporates a personalized approach with gradual PAP desensitization in addition to positive feedback and a reward system to encourage and maintain use. We also utilize behavioral therapy to encourage avoidance of supine sleep in order to decrease the severity of OSA in patients who do not accept or tolerate PAP. Surgical interventions based on assessment of the upper airway during sleep through dynamic imaging or sleep endoscopy may also be considered. A recent report of hypoglossal nerve stimulation therapy in an adolescent with severe OSA suggests a potentially new alternative option for therapy (Diercks et al. Pediatrics. 2016;137(5). doi: 10.1542/peds.2015-3663.
It seems intuitive that the management of sleep disorders in adult patients with DS positively contributes to their care and promotes their overall wellbeing. Adult patients with DS continue to present particular diagnostic and therapeutic challenges that have become even more complex as their life expectancy has increased. Further research and clinical guidelines are momentously needed in order to guide the management of sleep disorders for this particularly challenging patient population.
Dr. Shaib is Associate Professor of Medicine, Medical Director, Baylor St Luke’s Center for Sleep Medicine, Department of Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, Texas.
By Raysonho @ Open Grid Scheduler / Grid Engine (Own work)
